Forums › Ask ACCA Tutor Forums › Ask the Tutor ACCA AFM Exams › Mar/Jun 2017 Q3 b(ii)
- This topic has 3 replies, 2 voices, and was last updated 7 years ago by John Moffat.
- AuthorPosts
- August 21, 2017 at 8:14 pm #402829
Sorry John,
I clicked wrong button. Can you please kindly explain this to me?
I don’t understand the benefit Buryecs receive from swap:
5000x(.1430-.1315)x0.675=39m. Where is 0.675 from?
Thanks a lot.
August 21, 2017 at 9:23 pm #402835Hi John,
I have problem with the same question part c), the put option has right to sell at exercise price. exercise price is 7.75 while actual exchange rate is 7.6046, so the company can sell option at 7.75 and buy back at 7.6046, so the option should be exercised. When the option price is 7.25, the company should not exercise coz it can sell at actual price of 7.6046. I list the detailed calculation below:
exercise price 7.75. actual transaction: 7500/7.6046=€986
gain on options: 7500x(7.75-7.60)=$1125/7.6046=€148
premium paid: 1.6% x7500x.1430=(€17). Total of €1117Can you please point out my mistakes? Many thanks.
August 22, 2017 at 9:34 am #402909First question:
The benefit is on the $5,000 at time 3 (converting a current spot as opposed to the time 3 spot). The 0.675 is the discount factor for 3 years at 14%
August 22, 2017 at 9:36 am #402910Second question:
These are OTC options, and so they are not going to buy back. The either exercise the options at the exercise price, or they don’t exercise them.
- AuthorPosts
- The topic ‘Mar/Jun 2017 Q3 b(ii)’ is closed to new replies.